Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $87.1B | +$3.67B | 105 | 4.48% | Increased |
|
| 2 |
BlackRock
New York
| $83B | +$78.6B | 109 | 4.56% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $61.3B | +$1.29B | 85 | 5.47% | Increased |
|
| 4 |
Wellington Management Group
Boston,
Massachusetts
| $30.7B | -$647M | 36 | 7.4% | Reduced |
|
| 5 |
Fidelity Investments
Boston,
Massachusetts
| $27.9B | -$287M | 69 | 3.54% | Reduced |
|
| 6 |
Capital Research Global Investors
Los Angeles,
California
| $24B | -$1.61B | 10 | 7.56% | Reduced |
|
| 7 |
Capital World Investors
Los Angeles,
California
| $17.7B | -$4.23B | 13 | 4.22% | Reduced |
|
| 8 |
Bank of New York Mellon
New York
| $16.9B | +$36.5M | 94 | 4.68% | Increased |
|
| 9 |
Bank of America
Charlotte,
North Carolina
| $16.8B | +$356M | 102 | 3.35% | Increased |
|
| 10 |
Northern Trust
Chicago,
Illinois
| $16.2B | +$208M | 99 | 4.67% | Increased |
|
| 11 |
T. Rowe Price Associates
Baltimore,
Maryland
| $15.1B | +$797M | 56 | 2.84% | Increased |
|
| 12 |
Geode Capital Management
Boston,
Massachusetts
| $12.4B | +$920M | 110 | 5.11% | Increased |
|
| 13 |
JP Morgan Chase
New York
| $12.2B | -$1.24B | 74 | 2.8% | Reduced |
|
| 14 |
Norges Bank
Oslo,
Norway
| $12.1B | +$167M | 36 | 4.96% | Increased |
|
| 15 |
Wells Fargo
San Francisco,
California
| $10.7B | +$630M | 103 | 3.49% | Increased |
|
| 16 |
Morgan Stanley
New York
| $10.3B | +$477M | 118 | 3.17% | Increased |
|
| 17 |
Franklin Resources
San Mateo,
California
| $9.9B | +$509M | 46 | 5.02% | Increased |
|
| 18 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
| $9.28B | $0 | 7 | 13% | Maintained |
|
| 19 |
Primecap Management
Pasadena,
California
| $8.99B | +$185M | 14 | 8.16% | Increased |
|
| 20 |
Invesco
Atlanta,
Georgia
| $8.81B | -$128M | 37 | 2.89% | Reduced |
|
| 21 |
Ameriprise
Minneapolis,
Minnesota
| $8.13B | -$88.9M | 38 | 4.21% | Reduced |
|
| 22 |
Dodge & Cox
San Francisco,
California
| $8.02B | +$915M | 10 | 6.81% | Increased |
|
| 23 |
BBA
Baker Bros. Advisors
New York
| $7.89B | +$1.24B | 31 | 64.54% | Increased |
|
| 24 |
Goldman Sachs
New York
| $7.68B | +$1.19B | 81 | 2.08% | Increased |
|
| 25 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $6.89B | +$855M | 101 | 5.09% | Increased |
|